Stability analysis of a targeted chemotherapy-cancer model

Anusmita Das; Kaushik Dehingia; Nabajit Ray; Hemanta Kumar Sarmah; Anusmita Das; Kaushik Dehingia; Nabajit Ray; Hemanta Kumar Sarmah

doi:10.3934/mmc.2023011

Mathematical Modelling and Control

2023, Volume 3, Issue 2: 116-126. doi: 10.3934/mmc.2023011

Previous Article Next Article

Research article

Stability analysis of a targeted chemotherapy-cancer model

1.
Department of Mathematics, Udalguri College, Udalguri 784509, Assam, India
2.
Department of Mathematics, Sonari College, Sonari 785690, Assam, India
3.
Department of Mathematics, S.B. Deorah College, Guwahati 781007, Assam, India
4.
Department of Mathematics, Gauhati University, Guwahati 781014, Assam, India

Received: 05 November 2022 Revised: 13 February 2023 Accepted: 23 February 2023 Published: 05 June 2023

This study addresses a modified mathematical model of tumor growth with targeted chemotherapy consisting of effector cells, tumor cells, and normal cells. To investigate the dynamics of the model, local and global stability analyses have been performed at the equilibrium points of the model. It is found that the tumor-free steady state is globally asymptotically stable under certain conditions, which suggests that the prescribed treatment can eradicate tumor cells from the body for a threshold value of tumor growth rate. The main result of this study is that if the tumor growth rate is tiny, it is possible to eradicate the tumor from the body using a smaller amount of targeted chemotherapy drugs with less harm to the other healthy cells. If not, it requires a high dose of targeted chemotherapy drugs, which can increase the side effects of the drugs. Numerical simulations have been performed to verify our analytical results.

Keywords:

Citation: Anusmita Das, Kaushik Dehingia, Nabajit Ray, Hemanta Kumar Sarmah. Stability analysis of a targeted chemotherapy-cancer model[J]. Mathematical Modelling and Control, 2023, 3(2): 116-126. doi: 10.3934/mmc.2023011

Related Papers:

[1]	Xiao Xu, Hong Liao, Xu Yang . An automatic density peaks clustering based on a density-distance clustering index. AIMS Mathematics, 2023, 8(12): 28926-28950. doi: 10.3934/math.20231482
[2]	Fatimah Alshahrani, Wahiba Bouabsa, Ibrahim M. Almanjahie, Mohammed Kadi Attouch . $k$ NN local linear estimation of the conditional density and mode for functional spatial high dimensional data. AIMS Mathematics, 2023, 8(7): 15844-15875. doi: 10.3934/math.2023809
[3]	Shabbar Naqvi, Muhammad Salman, Muhammad Ehtisham, Muhammad Fazil, Masood Ur Rehman . On the neighbor-distinguishing in generalized Petersen graphs. AIMS Mathematics, 2021, 6(12): 13734-13745. doi: 10.3934/math.2021797
[4]	Yuming Chen, Jie Gao, Luan Teng . Distributed adaptive event-triggered control for general linear singular multi-agent systems. AIMS Mathematics, 2023, 8(7): 15536-15552. doi: 10.3934/math.2023792
[5]	Luca Bisconti, Paolo Maria Mariano . Global existence and regularity for the dynamics of viscous oriented fluids. AIMS Mathematics, 2020, 5(1): 79-95. doi: 10.3934/math.2020006
[6]	Hsin-Lun Li . Leader–follower dynamics: stability and consensus in a socially structured population. AIMS Mathematics, 2025, 10(2): 3652-3671. doi: 10.3934/math.2025169
[7]	Hongjie Li . Event-triggered bipartite consensus of multi-agent systems in signed networks. AIMS Mathematics, 2022, 7(4): 5499-5526. doi: 10.3934/math.2022305
[8]	Neelakandan Subramani, Abbas Mardani, Prakash Mohan, Arunodaya Raj Mishra, Ezhumalai P . A fuzzy logic and DEEC protocol-based clustering routing method for wireless sensor networks. AIMS Mathematics, 2023, 8(4): 8310-8331. doi: 10.3934/math.2023419
[9]	Yinwan Cheng, Chao Yang, Bing Yao, Yaqin Luo . Neighbor full sum distinguishing total coloring of Halin graphs. AIMS Mathematics, 2022, 7(4): 6959-6970. doi: 10.3934/math.2022386
[10]	Jin Cai, Shuangliang Tian, Lizhen Peng . On star and acyclic coloring of generalized lexicographic product of graphs. AIMS Mathematics, 2022, 7(8): 14270-14281. doi: 10.3934/math.2022786

Abstract

1. Introduction

Mathematics was initially utilized in biology in the $13^{th}$ century by Fibonacci, who developed the famed Fibonacci series to explain an increasing population. Daniel Bernoulli utilized mathematics to describe the impact on tiny shapes. Johannes Reinke coined the phrase "bio maths" in 1901. Biomathematics involves the theoretical examination of mathematical models to understand the principles governing the formation and functioning of biological systems.

Mathematical models are utilized to investigate specific questions related to the studied disease. For example, epidemiological models are important for predicting how infectious diseases spread, and help to control them by identifying important factors in the community. In this case, we want to analyze a particular model to understand how the COVID-19 virus behaves. This virus appeared in late 2019, and continues to be a global challenge. To gain a deeper insight into the underlying physical processes, we delve into the realm of fractional calculus. Previous literature has introduced various operators through the framework of fractional calculus ^[1,2]. In the field of C $^\eta$ -Calculus, Golmankhaneh et al. ^[3] provided an explanation of the Sumudu transform and Laplace transform. Additionally, in 2019, Goyal ^[4] proposed a fractional model that demonstrated the potential to manage the Lassa hemorrhagic fever disease.

Advancements in technology have led to significant progress in the field of epidemiology, enabling the examination of various infectious diseases for treatment, control, and cure ^[5]. It is essential to underscore that mathematical biology plays a pivotal role in investigating numerous diseases. Significant strides have been taken in the mathematical modeling of infectious diseases in recent decades, as evidenced by various studies ^[6,7]. Over the last thirty years, mathematical modeling has gained prominence in research, making substantial contributions to the development of effective public health strategies for disease control ^[8,9]. Mathematical models serve as invaluable tools for analyzing spatiotemporal patterns and the dynamic behavior of infections. Acknowledging their significance, researchers have approached the study of COVID-19 from diverse perspectives in the last three years ^[10,11].

Various methodologies have been employed by researchers in this field to devise successful techniques for managing this condition, with recent studies offering additional insights ^[12,13]. For example, a recent investigation utilized a mathematical model to evaluate the impacts of immunization in nursing homes ^[14]. Furthermore, researchers have explored mathematical modeling and effective intervention strategies for controlling the COVID-19 outbreak ^[15]. Additionally, some studies have delved into COVID-19 mathematical models using stochastic differential equations and environmental white noise ^[16].

In 2019, China experienced a notable outbreak of the coronavirus disease 2019 (COVID-19), prompting concerns about its potential to escalate into a worldwide pandemic ^[17]. Researchers from China, particularly Zhao et al., made significant contributions in addressing the challenges posed by COVID-19. This disease is attributed to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a viral infection. The initial verified case was documented in Wuhan, China, in December 2019 ^[18]. The infection rapidly spread worldwide, leading to the declaration of a COVID-19 pandemic.

Transmission occurs through various means, including respiratory droplets from coughing, sneezing, close contact, and touching contaminated surfaces. Key preventive measures include consistent mask usage, frequent hand washing, and maintaining safe interpersonal distances ^[19]. Effective interventions and real-time data play a crucial role in managing the coronavirus outbreak ^[20]. Prior studies have employed real-time analysis to comprehend the transmission of the virus among individuals, the severity of the disease, and the early stages of the pathogen, particularly in the initial week of the outbreak ^[21].

In December 2019, an outbreak of pneumonia cases was reported in Wuhan, initially with unidentified origins. Some cases were associated with exposure to wet markets and seafood. Chinese health authorities, in collaboration with the Chinese Center for Disease Control and Prevention (China CDC), initiated an investigation into the cause and spread of the disease on December 31, 2019 ^[22]. We conducted an analysis of temporal changes in the outbreak by examining the time interval between hospital admission dates and fatalities. Clinical studies on COVID-19 have indicated that symptoms typically manifest around 7 days after the onset of illness ^[23]. It is important to consider the duration between hospitalization and death in order to accurately assess the risk of mortality ^[24]. The information regarding the incubation period of COVID-19 and epidemiological data was sourced from publicly available records of confirmed cases ^[25].

An established method for the fractional-order model is elaborated upon in ^[26]. Recent contributions include various fractional models related to COVID-19, such as the analysis by Atangana and Khan focusing on the pandemic's impact on China ^[27]. Additionally, the COVID-19 model's dynamical aspects were explored using fuzzy Caputo and ABC derivatives, as demonstrated in ^[28]. A similar type of approach using fractional operator techniques are given in ^[29,30,31]. Different author's have investigated the transmission of different infectious disease like COVID-19 with symptomatic and asymptomatic effects in the community by using the fractal-fractional definition ^[32,33].

In light of the aforementioned significance, we aim is to address fundamental issues by concentrating on the distinctive challenges posed by the dynamics of COVID-19. To achieve this, we employ a model tailored to accurately capture the characteristics of COVID-19 dynamics and account for the limitations in our response to the pandemic. Initially, we examine the epidemic dynamics within a specific community characterized by a unique social pattern. For this analysis, we adopt a conventional SEIR design that accommodates prolonged incubation periods.

Here, the previous model is given in ^[34] as follows:

$\begin{eqnarray} \frac{dS}{dt}& = &\textbf{a}-\frac{\rho_{1} S I}{1+\gamma I}-(\delta+\rho)S,\\ \frac{dE}{dt}& = &\rho S-\delta E-\rho_{2}\alpha E I,\\ \frac{dI}{dt}& = &\frac{\rho_{1} S I}{1+\gamma I}\,\,+\rho_{2}\,\alpha\, E I-(\delta+\mu_{0}+\omega-\textbf{b})\,I,\\ \frac{dR}{dt}& = &\omega I-\delta R. \end{eqnarray}$

(1.1)

Initial conditions corresponds to the aforementioned system:

$\begin{equation*} S^{0}(t) \, = \, S_{0},\, \, E^{0}(t) \, = \, E_{0}, \, \,I^{0}(t) \, = \, I_{0},\,\, R^{0}(t)\, = \, R_{0}. \end{equation*}$

The primary goal of this research is to employ novel fractional derivatives within mathematical analysis and simulation to enhance the COVID-19 model. COVID-19 is a highly dangerous disease that presents a significant risk to human life. Verification of the existence and distinct characteristics of the solution system is undertaken, coupled with a qualitative assessment of the system. So, we introduce vaccination measures for low immune individuals. We developed new mathematical model by taking vaccination measures which helps to control COVID-19 early which we shall observe on simulation easily. The research involves confirming the presence of a solution system with unique characteristics and conducting a qualitative evaluation of this system. Furthermore, the fractal-fractional derivative is utilized to investigate the real-world behavior of the newly developed mathematical model. Finally, numerical simulations are used to reinforce and authenticate the biological findings.

Definition 1.1. If 0 $< \xi \leq$ 1 and 0 $< \lambda \leq$ 1, then the Riemann-Liouville operator for the fractal-fractional Operator (FFO) with a Mittag-Leffler (ML) kernel is defined as $U(t)$ ^[35].

$\begin{eqnarray} ^{FFM}_{0} D_{t}^{\xi, \lambda} U(t) = \frac{A B(\xi)}{1- \xi} \int^{t}_{0} E_{\xi} \frac{d \,U(\Omega)}{dt^{\lambda}}\left[- \frac{\xi}{1- \xi} (t-\Omega)^{\xi}\right] {d \Omega}\,\,, \end{eqnarray}$

involving $0 \; < \; \xi, \; \lambda \; \leq \; 1$ , and $AB(\xi) = 1 - \xi + \frac{\xi}{\Gamma(\xi)}.$

Therefore, the function $U(t)$ , which has an order of $(\xi, \lambda)$ and a Mittag-Leffler (ML) kernel, is given as follows:

$\begin{eqnarray} ^{FFM}_{0} D_{t}^{\xi, \lambda} U(t) = \frac{\lambda(1-\xi) t^{\lambda -1} U(t)}{A B(\xi)} + \frac{\xi \lambda}{A B(\xi)} \int^{t}_{0} {\Omega}^{\xi -1} (t-\Omega) U(\Omega) {d \Omega} \,\,. \end{eqnarray}$

2. Formulation of the SEVIR model

A newly developed model for SARS-COVID-19 includes the vaccinated effect, whereas the previous model used the SEIR framework. In this new model, we introduce a new variable called "Vaccinated." With the addition of Vaccinated, the new model is referred to as SEVIR, where "S" represents the Susceptible class, "E" represents the Exposed class, "V" represents the Vaccinated class, "I" represents the Infected class, and "R" represents the Recovered class.

We define several parameters in this model: "a" represents the recruitment rate, " $\delta$ " represents the death rate due to natural causes, " $\rho+\rho_{1}$ " represents the contact rate from the Susceptible class to the Exposed class, " $\rho_{2}$ " represents the vaccination rate, " $\alpha$ " represents the rate at which the infection is reducing due to vaccination effects, " $\mu_{0}$ " represents the infection death rate, " $\omega$ " represents the rate at which an individual recovers from vaccination and becomes recovered, " $\textbf{b}$ " represents the recruitment rate to the Vaccinated class, " $\phi$ " represents the contact rate from the Vaccinated class to the Infected class, and " $\psi$ " represents the recovery rate.

We want to investigate spread of the SEIR model for SARS-COVID-19 with the vaccinated effect.

So, the flow chart for newly developed model SEVIR is given as Figure 1.

Figure 1. The flow chart illustrates the newly developed model.

DownLoad: Full-Size Img PowerPoint

The model that was developed based on the generalized hypothesis with the vaccinated effect is presented as follows:

$\begin{eqnarray} \frac{d S}{dt}& = &\textbf{a}-(\delta+\rho+\rho_{1})S,\\ \frac{d E}{dt}& = &(\rho+\rho_{1})S-\delta E-\rho_{2}\alpha E V,\\ \frac{d V}{dt}& = &\rho_{2}\alpha E V-(\delta+\mu_{0}+\omega-\textbf{b}+\phi)V,\\ \frac{d I}{dt}& = &\phi V-(\mu_{0}+\delta+\psi)I,\\ \frac{d R}{dt}& = &\omega V+\psi I -\delta R. \end{eqnarray}$

(2.1)

The following are initial conditions linked with the described system:

$\begin{eqnarray} S^{0}(t) \, = \, S_{0},\, \, E^{0}(t) \, = \, E_{0}, \, \,V^{0}(t) \, = \, V_{0}, \, \,I^{0}(t) \, = \, I_{0},\,\, R^{0}(t)\, = \, R_{0}. \end{eqnarray}$

Using the fractal-fractional order (FFO) with a Mittag-Leffler (ML) definition, the above model becomes

$\begin{eqnarray} ^{FFM}_{0}D^{\xi,\lambda}_{t}S(t)& = &\textbf{a}-(\delta+\rho+\rho_{1})S,\\ ^{FFM}_{0}D^{\xi,\lambda}_{t}E(t)& = &(\rho+\rho_{1})S-\delta E-\rho_{2}\alpha E V,\\ ^{FFM}_{0}D^{\xi,\lambda}_{t}V(t)& = &\rho_{2}\alpha E V-(\delta+\mu_{0}+\omega-\textbf{b}+\phi)V,\\ ^{FFM}_{0}D^{\xi,\lambda}_{t}I(t)& = &\phi V-(\mu_{0}+\delta+\psi)I,\\ ^{FFM}_{0}D^{\xi,\lambda}_{t}R(t)& = &\omega V+\psi I-\delta R. \end{eqnarray}$

(2.2)

Here, $^{FFM}_{0}D^{\xi, \lambda}_{t}$ is the fractal-fractional operator with Mittag-Leffler (ML), where $0 < \xi \leq 1$ and $0 < \lambda \leq\; 1$ .

The following are initial conditions linked with the described system:

$\begin{eqnarray} S^{0}(t) \, = \, S_{0},\, \, E^{0}(t) \, = \, E_{0}, \, \,V^{0}(t) \, = \, V_{0}, \, \,I^{0}(t) \, = \, I_{0},\,\, R^{0}(t)\, = \, R_{0}. \end{eqnarray}$

Parameter descriptions are given in the following table.

Parameters	Representation	Reference
$\text{a}$	$\text{contact rate from the susceptible to the exposed class}$	^[34]
$\delta$	$\text{death rate due to natural causes}$	^[34]
$\rho+\rho_{1}$	$\text{contact rate from the susceptible to the exposed class}$	^[34]
$\alpha$	$\text{rate at which the infection is reducing due to vaccination}$	^[34]
$\rho_{2}$	$\text{vaccination rate}$	^[34]
$\mu_{0}$	death rate due to infection	^[34]
$\omega$	rate at which an individuals becomes recovered	^[34]
$\text{b}$	recruitment rate to the vaccinated class	^[34]
$\phi$	contact rate from the vaccinated to the infected class	Assumed
$\psi$	recovery rate	Assumed

2.1. Equilibrium point and reproductive number

For this model, the point of equilibrium without disease (disease free) is

$\begin{eqnarray} D_{1}(S,\,E,\,V,\,I,\,R) = \left(\frac{\textbf{a}}{\delta+\rho+\rho_{1}},\frac{\textbf{a}(\rho+\rho_{1})}{\delta(\delta+\rho+\rho_{1})},0,0,0\right), \end{eqnarray}$

as well as the endemic points of equilibrium $D_{2}(S^{*}, E^{*}, V^{*}, I^{*}, R^{*})$ , where

$\begin{eqnarray} S^{*}& = &\frac{\textbf{a}}{\delta+\rho+\rho_{1}},\\ E^{*}& = &\frac{-\textbf{b}+\delta+\phi+\omega+\mu_{0}}{\alpha\rho_{2}},\\ V^{*}& = &\frac{(\delta+\psi+\mu_{0})\textbf{A}-\textbf{b}\delta\rho_{1}+\delta^{2}\rho_{1}+\delta\phi\rho_{1}+\delta\omega\rho_{1}+\delta\mu_{0}\rho_{1}-\textbf{a}\alpha\rho\rho_{2}-\textbf{a}\alpha\rho_{1}\rho_{2}}{\alpha \phi(\textbf{b}-\delta-\phi-\omega-\mu_{0})(\delta+\rho+\rho_{1})\rho_{2}},\\ I^{*}& = &\phi\Bigg(\frac{\textbf{A}-\textbf{b}\delta\rho_{1}+\delta^{2}\rho_{1}+\delta\phi\rho_{1}+\delta\omega\rho_{1}+\delta\mu_{0}\rho_{1}-\textbf{a}\alpha\rho\rho_{2}-\textbf{a}\alpha\rho_{1}\rho_{2}}{\alpha(\textbf{b}-\delta-\phi-\omega-\mu_{0})(\delta+\rho+\rho_{1})\rho_{2}}\Bigg),\\ R^{*}& = &\big(\phi\psi+\delta\omega+\psi\omega+\omega\mu_{0}\big)\times\Bigg(\frac{\textbf{A}-\textbf{b}\delta\rho_{1}+\delta^{2}\rho_{1}+\delta\phi\rho_{1}+\delta\omega\rho_{1}+\delta\mu_{0}\rho_{1}-\textbf{a}\alpha\rho\rho_{2}-\textbf{a}\alpha\rho_{1}\rho_{2}}{\alpha \delta \phi(\delta+\psi+\mu_{0})(\textbf{b}-\delta-\phi-\omega-\mu_{0})(\delta+\rho+\rho_{1})\rho_{2}}\Bigg), \end{eqnarray}$

where

$\begin{eqnarray} \textbf{A} = -\textbf{b}\delta^{2}+\delta^{3}-\textbf{b}\delta\rho+\delta^{2}\rho+\delta^{2}\phi +\delta\rho\phi+\delta^{2}\omega+\delta\rho\omega+\delta^{2}\mu_{0}+\delta\rho\mu_{0}. \end{eqnarray}$

The reproductive number for the newly developed system by using the next generation method is

$\begin{eqnarray} R_{0} = \frac{\textbf{b}\delta(\delta+\rho+\rho_{1})+\textbf{a}\alpha\rho_{2}(\rho+\rho_{1})}{\delta(\delta+\rho+\rho_{1})(\delta+\phi+\omega+\mu_{0})}. \end{eqnarray}$

3. Bounded and positive solutions

In this section, we demonstrate the boundedness and positivity of the developed model.

Theorem 3.1. The considered initial condition is

$\begin{eqnarray} \{S_{0},E_{0}, V_{0},I_{0},R_{0}\}\subset\Upsilon, \end{eqnarray}$

and therefore the solutions $\{ S, E, V, I, R \}$ will be positive $\forall$ t $\geq$ 0.

Proof. We will begin the primary analysis to show the improved quality of the solutions. These solutions effectively address real-world issues and have positive outcomes. We will follow the methodology provided in references ^[36,37,38]. In this segment, we will examine the conditions required to ensure positive outcomes from the proposed model. To accomplish this, we will establish a standard.

$\begin{eqnarray} \parallel \beta \parallel_{\infty} = \sup\limits_{t\in D_{\beta}}\mid\beta(t)\mid, \end{eqnarray}$

where " $D_{\beta}$ " represents the $\beta$ domain. Now, we continue with $S(t)$ .

$\begin{eqnarray} ^{FFM}_{0}D^{\xi,\lambda}_{t}S(t)& = &\textbf{a}-(\delta+\rho+\rho_{1})S, \quad \forall t\geq0,\\ &\geq&-\left(\delta+\rho+\rho_{1}\right)S, \quad \forall t\geq0. \end{eqnarray}$

This yield

$\begin{eqnarray} S(t)\geq S(0)E_{\xi}\bigg[-\frac{c^{1-\lambda}{\xi}{(\delta+\rho+\rho_{1})}{t^{\xi}}}{{A B}(\xi)-(1-\xi)(\delta+\rho+\rho_{1})}\bigg], \quad \forall t\geq0, \end{eqnarray}$

where "c" represents the time element. This demonstrates that the $S(t)$ individuals must be positive $\forall \, \, t \geq$ 0. Now, we have the $E(t)$ individuals as follows:

$\begin{eqnarray} ^{FFM}_{0}D^{\xi,\lambda}_{t}E(t)& = &(\rho+\rho_{1})S-\delta E-\rho_{2}\alpha E V, \quad \forall \,\, t\geq0,\\ &\geq&-(\delta+\rho_{2}\alpha\mid V \mid)E, \quad \forall \,\,t\geq0,\\ &\geq&-(\delta+\rho_{2}\alpha\sup\limits_{t\in D_{V}}\mid V \mid )E, \quad \forall \,\,t\geq0,\\ &\geq&-(\delta+\rho_{2}\alpha\parallel V \parallel_{\infty})E, \quad \forall \,\,t\geq 0. \end{eqnarray}$

This yield

$\begin{eqnarray} E(t)\geq E(0)E_{\xi}\bigg[-\frac{c^{1-\lambda}{\xi}{(\delta+\rho_{2}\alpha\parallel V\parallel_{\infty})}{t^{\xi}}}{AB(\xi)-(1-\xi)(\delta+\rho_{2}\alpha\parallel V\parallel_{\infty})}\bigg], \quad \forall \,\,t\geq0, \end{eqnarray}$

where "c" represents the time element. This demonstrates that the $E(t)$ individuals must be positive $\forall \, \, t \geq$ 0. Now, we have the $V(t)$ individuals as follows:

$\begin{eqnarray} ^{FFM}_{0}D^{\xi,\lambda}_{t}V(t)& = &\rho_{2}\alpha E I-(\delta+\mu_{0}+\omega-\textbf{b}+\phi)V, \quad \forall t\geq0,\\ &\geq&-(-\rho_{2}\alpha \mid E \mid+\mu_{0}+\delta+\omega-\textbf{b}+\phi)V, \quad \forall t\geq0,\\ &\geq&-(-\rho_{2}\alpha \sup\limits_{t\in D_{E}}\mid E \mid+\mu_{0}+\delta+\omega-\textbf{b}+\phi)V, \quad \forall t\geq0,\\ &\geq&-(-\rho_{2}\alpha \parallel E \parallel_{\infty}+\mu_{0}+\delta+\omega-\textbf{b}+\phi)V, \quad \forall t\geq0. \end{eqnarray}$

This yield

$\begin{eqnarray} V(t)\geq V(0)E_{\xi}\bigg[-\frac{c^{1-\lambda{\xi}}{(-\rho_{2}\alpha \parallel E \parallel_{\infty}+\mu_{0}+\delta+\omega-\textbf{b}+\phi)}{t^{\xi}}}{A B(\xi)-(1-\xi)\left(-\rho_{2}\alpha\parallel E \parallel_{\infty}+\mu_{0}+\delta+\omega-\textbf{b}+\phi\right)}\bigg], \quad \forall t\geq0, \end{eqnarray}$

where "c" represents the time element. This demonstrates that the $V(t)$ individuals must be positive $\forall \, \, t \geq$ 0. Now, we have the $I(t)$ individuals as follows:

$\begin{eqnarray} ^{FFM}_{0}D^{\xi,\lambda}_{t}I(t)& = &\phi V-(\mu_{0}+\delta+\psi)I, \quad \forall t\geq0,\\ &\geq&-(\mu_{0}+\delta+\psi)I(t), \quad \forall t\geq0. \end{eqnarray}$

This yield

$\begin{eqnarray} I(t)\geq I(0)E_{\xi}\bigg[-\frac{c^{1-\lambda}{\xi}{(\mu_{0}+\delta+\psi)}{t^{\xi}}}{A B(\xi)-(1-\xi)(\mu_{0}+\delta+\psi)}\bigg], \quad \forall t\geq0, \end{eqnarray}$

where "c" represents the time element. This demonstrates that the $I(t)$ individuals must be positive $\forall \, \, t \geq$ 0. Now, we have the $R(t)$ individuals as follows:

$\begin{eqnarray} ^{FFM}_{0}D^{\xi,\lambda}_{t}R(t)& = &\omega V+\psi I-\delta R , \quad \forall \,t\,\geq\,0,\\ &\geq&-(\delta)R(t), \quad \forall \,t\,\geq\,0. \end{eqnarray}$

This yield

$\begin{eqnarray} R(t)\geq R(0){E_{\xi}}\bigg[-\frac{c^{1-\lambda}\xi{(\delta)}{t^{\xi}}}{{A B}(\xi)-(1-\xi)(\delta)}\bigg], \quad \forall t\geq0, \end{eqnarray}$

where "c" represents the time element. This demonstrates that the $R(t)$ individuals must be positive $\forall \, \, t \geq$ 0.

Theorem 3.2. Solutions of our developed model given in Eq (2.2) with positive initial values are all bounded.

Proof. The above theorem demonstrates that the solutions of our developed model must be positive $\forall \, \, t\, \geq\, 0$ , and the strategies are described in ^[39]. Because $X = S\, +\, E\, +\, V$ , then

$\begin{eqnarray} ^{FFM}_{0}D^{\xi,\lambda}_{t}X(t) = \textbf{a}-\delta X-(\mu_{0}+\omega-\textbf{b}+\phi)V. \end{eqnarray}$

We achieved as follows:

$\begin{eqnarray} \Psi_{p} = \{S,\quad E,\quad V \in R_{+}^{3}\mid S + V\leq X\} \quad \forall \,\,t\geq0. \end{eqnarray}$

Further we have $X_{\upsilon}$ = I+R. So, we have

$\begin{eqnarray} ^{FFM}_{0}D^{\xi,\lambda}_{t}X_{\upsilon}(t) = (\phi+\omega)V-\mu_{0}I-X_{\upsilon}\delta. \end{eqnarray}$

Upon solving the above equation and taking $t\rightarrow \infty$ , we get

$\begin{eqnarray} X_{\upsilon}\leq\frac{(\phi+\omega)V-\mu_{0}I}{\delta}. \end{eqnarray}$

Thus,

$\begin{eqnarray} \Psi_{\upsilon} = \bigg\{I,\,\,R\in R_{+}^{2}\mid X_{\upsilon}\leq\frac{(\phi+\omega)I-\mu_{0}Q}{\delta}\bigg\} \quad \forall \,\,t \geq 0. \end{eqnarray}$

The model's mathematical solutions (2.2) are confined to the region $\Psi$ .

$\begin{eqnarray} \Psi = \bigg\{S,\,\,E,\,\,V,\,\,I,\,\,R \in R_{+}^{5}\mid S+V\leq X,X_{\upsilon}\leq\frac{(\phi+\omega)V-\mu_{0}I}{\delta}\bigg\} \quad \forall \,\,t\geq0. \end{eqnarray}$

This demonstrates that for every $t \geq$ 0, all solutions remain positive, consistent with the provided initial conditions in the domain $\Psi$ .

Theorem 3.3. The proposed coronavirus model (2.2) in $R_{+}^{5}$ has positive invariant solutions, in addition to the initial conditions.

Proof. In this particular scenario, we applied the procedure described in ^[40]. We have

$\begin{eqnarray} ^{FFM}_{0}D^{\xi,\lambda}_{t}(S(t))_{S = 0}& = &\textbf{a} \quad \geq0,\\ ^{FFM}_{0}D^{\xi,\lambda}_{t}(E(t))_{E = 0}& = &(\rho+\rho_{1})S \quad \geq0,\\ ^{FFM}_{0}D^{\xi,\lambda}_{t}(V(t))_{V = 0}& = &\rho_{2}\alpha E V+\textbf{b}V \quad \geq0,\\ ^{FFM}_{0}D^{\xi,\lambda}_{t}(I(t))_{I = 0}& = &\phi V \quad \geq0,\\ ^{FFM}_{0}D^{\xi,\lambda}_{t}(R(t))_{R = 0}& = &\omega V+\psi I \quad \geq0. \end{eqnarray}$

(3.1)

If $(S_{0}, E_{0}, V_{0}, I_{0}, R_{0})$ $\in$ $R_{+}^{5}$ , then our obtained solution is unable to escape from the hyperplane, as stated in Eq (3.1). This proves that the $R_{+}^{5}$ domain is positive invariant.

4. Impact of global derivatives for uniqueness and existence of solutions

The Riemann-Stieltjes integral has been widely recognized in the literature as the most commonly used integral. If

$\begin{eqnarray} Y(x) = \int y(x){d}x, \end{eqnarray}$

then the Riemann-Stieltjes integral is given as follows:

$\begin{eqnarray} Y_{w}(x) = \int y(x){d}{w}(x), \end{eqnarray}$

where the $y(x)$ global derivative with respect to $w(x)$ is

$\begin{eqnarray} D_{w}y(x) = \lim\limits_{h\rightarrow0}\frac{y(x+h)-y(x)}{w(x+h)-w(x)}. \end{eqnarray}$

If the above function's numerator and denominator are differentiated, we get

$\begin{eqnarray} D_{w}y(x) = \frac{y^{'}(x)}{w^{'}(x)}, \end{eqnarray}$

assuming that $w^{'}(x)\, \, \neq$ 0, $\forall x\in D_{w^{'}}$ . Now, we will test the impact on the coronavirus by using the global derivative instead of the classical derivative:

$\begin{eqnarray} D_{w}S& = &\textbf{a}-(\delta+\rho+\rho_{1})S,\\ D_{w}E& = &(\rho+\rho_{1})S-\delta E-\rho_{2}\alpha E V,\\ D_{w}V& = &\rho_{2}\alpha E V-(\delta+\mu_{0}+\omega-\textbf{b}+\phi)V,\\ D_{w}I& = &\phi V-(\mu_{0}+\delta+\psi)I,\\ D_{w}R& = &\omega V+\psi I-\delta R. \end{eqnarray}$

For the sake of clean notation, we shall suppose that w is differentiable.

$\begin{eqnarray} S^{'}& = &w^{'}[\textbf{a}-(\delta+\rho+\rho_{1})S],\\ E^{'}& = &w^{'}[(\rho+\rho_{1})S-\delta E-\rho_{2}\alpha E V],\\ V^{'}& = &w^{'}[\rho_{2}\alpha E V-(\delta+\mu_{0}+\omega-\textbf{b}+\phi)V],\\ I^{'}& = &w^{'}[\phi V-(\mu_{0}+\delta+\psi)I],\\ R^{'}& = &w^{'}[\omega V+\psi I-\delta R]. \end{eqnarray}$

An appropriate choice of the function $w(t)$ will lead to a specific outcome. For instance, if $w(t) = t^{\alpha}$ , where $\alpha$ is a real number, we will observe fractal movement. We had to take action due to the circumstances that

$\begin{eqnarray} \parallel w^{'}\parallel_{\infty} = \sup\limits_{t\in D_{w^{'}}}\mid w^{'}(t)\mid < N. \end{eqnarray}$

The below example demonstrates the unique solution for the developed system:

$\begin{eqnarray} S^{'}& = &w^{'}[\textbf{a}-(\delta+\rho+\rho_{1})S] = Z_{1}(t, S, G),\\ E^{'}& = &w^{'}[(\rho+\rho_{1})S-\delta E-\rho_{2}\alpha E V] = Z_{2}(t, S, G),\\ V^{'}& = &w^{'}[\rho_{2}\alpha E V-(\delta+\mu_{0}+\omega- \textbf{b}+\phi)V] = Z_{3}(t, S, G), \\ I^{'}& = &w^{'}[\phi V-(\mu_{0}+\delta+\psi)I] = Z_{4}(t, S, G),\\ R^{'}& = &w^{'}[\omega V+\psi I-\delta R] = Z_{5}(t, S, G), \end{eqnarray}$

where $G = E, V, I, R$ .

We need to confirm the first two requirements as follows:

(1) $\mid Z(t, S, G)\mid^{2} < K(1+\mid S\mid^{2}$ ,

(2) $\forall \quad S_{1}, S_{2}$ , we have, $\parallel Z(t, S_{1}, G)-Z(t, S_{2}, G)\parallel^{2} < \bar{K}\parallel S_{1}-S_{2}\parallel_{\infty}^{2}$ .

Initially,

$\begin{eqnarray} \mid Z_{1}(t, S, G)\mid^{2}& = &\mid w^{'}\big[\textbf{a}-(\delta+\rho+\rho_{1})S\big]\mid^{2},\\ & = &\mid w^{'}\big[\textbf{a}+\left(-\delta-\rho-\rho_{1}\right)S\big]\mid^{2},\\ &\leq&2\mid w^{'}\mid^{2}\left(\textbf{a}^{2}+\mid(-\delta-\rho-\rho_{1})S\mid^{2}\right),\\ &\leq&2\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}\textbf{a}^{2}+6\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}\left(\rho^{2}+\delta^{2}+\rho_{1}\right)\mid S\mid^{2},\\ &\leq&2\parallel w^{'}\parallel^{2}_{\infty}\textbf{a}^{2}+6\parallel w^{'}\parallel^{2}_{\infty}\left(\rho^{2}+\delta^{2}+\rho_{1}^{2}\right)\mid S\mid^{2},\\ &\leq&2\parallel w^{'}\parallel^{2}_{\infty}\textbf{a}^{2}\left(1+\frac{3}{\textbf{a}^{2}}(\rho^{2}+\delta^{2}+\rho_{1}^{2})\mid S\mid^{2}\right),\\ &\leq&K_{1}(1+\mid S\mid^{2}), \end{eqnarray}$

under the condition

$\begin{eqnarray} \frac{3}{\textbf{a}^{2}}(\rho^{2}+\delta^{2}+\rho_{1}^{2}) < 1, \end{eqnarray}$

involving

$\begin{eqnarray} K_{1} = 2\parallel w^{'}\parallel^{2}_{\infty}\textbf{a}^{2}. \end{eqnarray}$

$\begin{eqnarray} \mid Z_{2}(t, S, G)\mid^{2}& = &\mid w^{'}\big[(\rho+\rho_{1})S-\delta E-\rho_{2}\alpha E V\big]\mid^{2},\\ & = &\mid w^{'}\big[(\rho+\rho_{1})S+(-\delta-\rho_{2}\alpha V)E\big]\mid^{2},\\ &\leq&2\mid w^{'}\mid^{2}\left(\mid(\rho+\rho_{1})S\mid^{2}+(-\delta-\rho_{2}\alpha V)E\mid^{2}\right),\\ &\leq&4\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}(\rho^{2}+\rho_{1}^{2})\sup\limits_{t\in D_{S}}\mid S\mid^{2}+4\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}(\delta^{2}+\rho^{2}_{2}\alpha^{2}\sup\limits_{t\in D_{V}}\mid V \mid^{2})\mid E\mid^{2},\\ &\leq&4\parallel w^{'}\parallel^{2}_{\infty}(\rho^{2}+\rho_{1}^{2})\parallel S\parallel^{2}_{\infty}+4\parallel w^{'}\parallel^{2}_{\infty}(\delta^{2}+\rho^{2}_{2}\alpha^{2}\parallel V \parallel^{2}_{\infty})\mid E\mid^{2},\\ &\leq&4\parallel w^{'}\parallel^{2}_{\infty}(\rho^{2}+\rho_{1}^{2})\parallel S\parallel^{2}_{\infty}\left(1+\frac{(\delta^{2}+\rho^{2}_{2}\alpha^{2}\parallel V \parallel^{2}_{\infty})\mid E\mid^{2}}{(\rho^{2}+\rho_{1}^{2})\parallel S\parallel^{2}_{\infty}}\right),\\ &\leq&K_{2}(1+\mid E\mid^{2}), \end{eqnarray}$

under the condition

$\begin{eqnarray} \frac{(\delta^{2}+\rho^{2}_{2}\alpha^{2}\parallel V \parallel^{2}_{\infty})}{(\rho^{2}+\rho_{1}^{2})\parallel S\parallel^{2}_{\infty}} < 1, \end{eqnarray}$

where

$\begin{eqnarray} K_{2} = 2\parallel w^{'}\parallel^{2}_{\infty}(\rho^{2}+\rho_{1}^{2})\parallel S\parallel^{2}_{\infty}. \end{eqnarray}$

$\begin{eqnarray} \mid Z_{3}(t, S, G)\mid^{2}& = &\mid w^{'}\big[\rho_{2}\alpha E V-(\delta+\mu_{0}+\omega-\textbf{b}+\phi)V\big]\mid^{2},\\ & = &\mid w^{'}\big[\rho_{2}\alpha E V+\textbf{b}V+(-\delta-\mu_{0}-\omega-\phi)V\big]\mid^{2},\\ &\leq&2\mid w^{'}\mid^{2}\left(\mid\rho_{2}\alpha E+\textbf{b}\mid^{2}+\mid(-\delta-\mu_{0}-\omega-\phi)\mid^{2}\right)\mid V \mid^{2},\\ &\leq&4\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}\big[(\rho_{2}^{2}\alpha^{2}\sup\limits_{t\in D_{E}}\mid E\mid^{2}+\textbf{b}^{2})+2(\delta^{2}+\mu_{0}^{2}+\omega^{2}+\phi^{2})\big]\mid V \mid^{2},\\ &\leq&4\parallel\mid w^{'}\parallel^{2}_{\infty}\bigg[(\rho_{2}^{2}\alpha^{2}\parallel E\parallel^{2}_{\infty}+\textbf{b}^{2})+2(\delta^{2}+\mu_{0}^{2}+\omega^{2}+\phi^{2})\bigg]\mid V \mid^{2},\\ &\leq&4\parallel\mid w^{'}\parallel^{2}_{\infty}(\rho_{2}^{2}\alpha^{2}\parallel E\parallel^{2}_{\infty}+\textbf{b}^{2})\bigg[1+\frac{2(\delta^{2}+\mu_{0}^{2}+\omega^{2}+\phi^{2})}{\left(\rho_{2}^{2}\alpha^{2}\parallel E\parallel^{2}_{\infty}+\textbf{b}^{2}\right)}\bigg]\mid V \mid^{2},\\ &\leq&K_{3}(2\mid V \mid^{2}), \end{eqnarray}$

under the condition

$\begin{eqnarray} \frac{2(\delta^{2}+\mu_{0}^{2}+\omega^{2}+\phi^{2})}{\left(\rho_{2}^{2}\alpha^{2}\parallel E\parallel^{2}_{\infty}+\textbf{b}^{2}\right)}\leq1, \end{eqnarray}$

where

$\begin{eqnarray} K_{3} = 4\parallel\mid w^{'}\parallel^{2}_{\infty}(\rho_{2}^{2}\alpha^{2}\parallel E\parallel^{2}_{\infty}+\textbf{b}^{2}). \end{eqnarray}$

$\begin{eqnarray} \mid Z_{4}(t, S, G)\mid^{2}& = &\mid w^{'}\big[\phi V-(\mu_{0}+\delta+\psi)I\big]\mid^{2},\\ & = &\mid w^{'}\big[\phi V+(-\mu_{0}-\delta-\psi)I\big]\mid^{2},\\ &\leq&2\mid w^{'}\mid^{2}\left(\mid\phi V \mid^{2}+\mid(-\mu_{0}-\delta-\psi)I\mid^{2}\right),\\ &\leq&2\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}\phi^{2}\sup\limits_{t\in D_{V}}\mid V \mid^{2}+6\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}(\mu_{0}^{2}+\delta^{2}+\psi^{2})\mid I \mid^{2},\\ &\leq&2\parallel w^{'}\parallel^{2}_{\infty}\phi^{2}\parallel V \parallel^{2}_{\infty}+6\parallel w^{'}\parallel^{2}_{\infty}(\mu_{0}^{2}+\delta^{2}+\psi^{2})\mid I\mid^{2},\\ &\leq&2\parallel w^{'}\parallel^{2}_{\infty}\phi^{2}\parallel I\parallel^{2}_{\infty}\left(1+\frac{3(\mu_{0}^{2}+\delta^{2}+\psi^{2})\mid I \mid^{2}}{\phi^{2}\parallel I\parallel^{2}_{\infty}}\right),\\ &\leq&K_{4}(1+\mid I \mid^{2}), \end{eqnarray}$

under the condition

$\begin{eqnarray} \frac{3(\mu_{0}^{2}+\delta^{2}+\psi^{2})}{\phi^{2}\parallel V \parallel^{2}_{\infty}} < 1, \end{eqnarray}$

where

$\begin{eqnarray} K_{4} = 2\parallel w^{'}\parallel^{2}_{\infty}\phi^{2}\parallel V \parallel^{2}_{\infty}. \end{eqnarray}$

$\begin{eqnarray} \mid Z_{5}(t, S, G)\mid^{2}& = &\mid w^{'}\big[\omega V+\psi I-\delta R\big]\mid^{2},\\ & = &\mid w^{'}\big[(\omega V+\psi I)+(-\delta R)\big]\mid^{2},\\ &\leq&2\mid w^{'}\mid^{2}\left(\mid(\omega V+\psi I)\mid^{2}+\mid-\delta R\mid^{2}\right),\\ &\leq&4\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}\left(\omega^{2}\sup\limits_{t\in D_{V}}\mid V \mid^{2}+\psi\sup\limits_{t\in D_{I}}\mid I \mid^{2}\right)+2\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}\delta^{2}\mid R\mid^{2},\\ &\leq&4\parallel w^{'}\parallel^{2}_{\infty}\left(\omega^{2}\parallel V \parallel^{2}_{\infty}+\psi\parallel I \parallel^{2}_{\infty}\right)+2\parallel w^{'}\parallel^{2}_{\infty}\delta^{2}\mid R\mid^{2}),\\ &\leq&4\parallel w^{'}\parallel^{2}_{\infty}(\omega^{2}\parallel V \parallel^{2}_{\infty}+\psi^{2}\parallel I\parallel^{2}_{\infty})\left(1+\frac{\delta^{2}\mid R\mid^{2}}{2(\omega^{2}\parallel V \parallel^{2}_{\infty}+\psi^{2}\parallel I \parallel^{2}_{\infty})}\right),\\ &\leq&K_{5}(1+\mid R\mid^{2}), \end{eqnarray}$

under the condition

$\begin{eqnarray} \frac{\delta^{2}}{2(\omega^{2}\parallel V \parallel^{2}_{\infty}+\psi^{2}\parallel I \parallel^{2}_{\infty})} < 1, \end{eqnarray}$

where

$\begin{eqnarray} K_{5} = 4\parallel w^{'}\parallel^{2}_{\infty}(\omega^{2}\parallel V \parallel^{2}_{\infty}+\psi^{2}\parallel I \parallel^{2}_{\infty}). \end{eqnarray}$

Hence the linear growth condition is satisfied.

Further, we validate the Lipschitz condition.

$\begin{eqnarray} \mid Z_{1}(t, S_{1}, G)-Z_{1}(t, S_{2}, G)\mid^{2}& = &\mid w^{'}(-\delta-\rho-\rho_{1})(S_{1}-S_{2})\mid^{2},\\ \mid Z_{1}(t, S_{1}, G)-Z_{1}(t, S_{2}, G)\mid^{2}&\leq&\mid w^{'}\mid^{2}(3\delta^{2}+3\rho^{2}+3\rho_{1}^{2})\mid S_{1}-S_{2}\mid^{2},\\ \sup\limits_{t\in D_{S}}\mid Z_{1}(t, S_{1}, G)-Z_{1}(t, S_{2}, G)\mid^{2}&\leq&\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}\left(3\delta^{2}+3\rho^{2}+3\rho_{1}^{2}\right)\sup\limits_{t\in D_{S}}\mid S_{1}-S_{2}\mid^{2},\\ \parallel Z_{1}(t, S_{1}, G)-Z_{1}(t, S_{2}, G)\parallel_{\infty}^{2}&\leq&\parallel w^{'}\parallel^{2}_{\infty}(3\delta^{2}+3\rho^{2}+3\rho_{1}^{2})\parallel S_{1}-S_{2}\parallel^{2}_{\infty},\\ \parallel Z_{1}(t, S_{1}, G)-Z_{1}(t, S_{2}, G)\parallel_{\infty}^{2}&\leq&\bar{K_{1}}\parallel S_{1}-S_{2}\parallel^{2}_{\infty}, \end{eqnarray}$

where

$\begin{eqnarray} \bar{K_{1}} = \parallel w^{'}\parallel^{2}_{\infty}\left(3\delta^{2}+3\rho^{2}+3\rho_{1}^{2}\right). \end{eqnarray}$

$\begin{eqnarray} \mid Z_{2}(t,\,\,S,\,\,E_{1},\,\,V,\,\,I,\,\,R)-Z_{2}(t,\,\,S,\,\,E_{2},\,\,V,\,\,I,\,\,R)\mid^{2}& = &\mid w^{'}(-\delta-\rho_{2}\alpha V)(E_{1}-E_{2})\mid^{2},\\ \mid Z_{2}(t,\,\,S,\,\,E_{1},\,\,V,\,\,I,\,\,R)-Z_{2}(t,\,\,S,\,\,E_{2},\,\,V,\,\,I,\,\,R)\mid^{2}&\leq&\mid w^{'}\mid^{2}(2\delta^{2}+2\rho_{2}^{2}\alpha^{2}\mid V \mid^{2})\mid E_{1}-E_{2}\mid^{2},\\ \sup\limits_{t\in D_{E}}\mid Z_{2}(t,\,\,S,\,\,E_{1},\,\,V,\,\,I,\,\,R)-Z_{2}(t,\,\,S,\,\,E_{2},\,\,V,\,\,I,\,\,R)\mid^{2}&\leq&\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}(2\delta^{2}+2\rho_{2}^{2}\alpha^{2}\sup\limits_{t\in D_{V}}\mid V \mid^{2})\sup\limits_{t\in D_{E}}\\&&\times\mid E_{1}-E_{2}\mid^{2},\\ \parallel Z_{2}(t,\,\,S,\,\,E_{1},\,\,V,\,\,I,\,\,R)-Z_{2}(t,\,\,S,\,\,E_{2},\,\,V,\,\,I,\,\,R)\parallel_{\infty}^{2}&\leq&\parallel w^{'}\parallel^{2}_{\infty}(2\delta^{2}+2\rho_{2}^{2}\alpha^{2}\parallel V \parallel^{2}_{\infty}),\parallel E_{1}-E_{2}\parallel^{2}_{\infty},\\ \parallel Z_{2}(t,\,\,S,\,\,E_{1},\,\,V,\,\,I,\,\,R)-Z_{2}(t,\,\,S,\,\,E_{2},\,\,V,\,\,I,\,\,R)\parallel_{\infty}^{2}&\leq&\bar{K_{2}}\parallel E_{1}-E_{2}\parallel^{2}_{\infty}, \end{eqnarray}$

where

$\begin{eqnarray} \bar{K_{2}} = \parallel w^{'}\parallel^{2}_{\infty}(2\delta^{2}+2\rho_{2}^{2}\alpha^{2}\parallel V \parallel^{2}_{\infty}). \end{eqnarray}$

$\begin{eqnarray} &&\mid Z_{3}(t,\,\,S,\,\,E,\,\,V_{1},\,\,I,\,\,R)-Z_{3}(t,\,\,S,\,\,E,\,\,V_{2},\,\,I,\,\,R)\mid^{2}\\& = &\mid w^{'}\left(\rho_{2}\alpha E+\textbf{b}+(-\delta-\mu_{0}-\omega-\phi)\right)(V_{1}-V_{2})\mid^{2}, \end{eqnarray}$

$\begin{eqnarray} &&\mid Z_{3}(t,\,\,S,\,\,E,\,\,V_{1},\,\,I,\,\,R)-Z_{3}(t,\,\,S,\,\,E,\,\,V_{2},\,\,I,\,\,R)\mid^{2}\\&\leq&2\mid w^{'}\mid^{2}\left(\mid\rho_{2}\alpha E+\textbf{b}\mid^{2}+\mid(-\delta-\mu_{0}-\omega-\phi)\mid^{2}\right)\\&&\times\mid V_{1}-V_{2}\mid^{2}, \end{eqnarray}$

$\begin{eqnarray} \sup\limits_{t\in D_{V}}\mid Z_{3}(t,\,\,S,\,\,E,\,\,V_{1},\,\,I,\,\,R)-Z_{3}(t,\,\,S,\,\,E,\,\,V_{2},\,\,I,\,\,R)\mid^{2}&\leq&4\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}\bigg(\rho_{2}^{2}\alpha^{2}\sup\limits_{t\in D_{E}}\mid E\mid^{2}+\textbf{b}^{2}\\&&+2(\delta^{2}+\mu_{0}^{2}+\omega^{2}+\phi^{2})\bigg)\sup\limits_{t\in D_{V}}\mid V_{1}-V_{2}\mid^{2},\\ \parallel Z_{3}(t,\,\,S,\,\,E,\,\,V_{1},\,\,I,\,\,R)-Z_{3}(t,\,\,S,\,\,E,\,\,V_{2},\,\,I,\,\,R)\parallel_{\infty}^{2}&\leq&4\parallel w^{'}\parallel^{2}_{\infty}\bigg(\rho_{2}^{2}\alpha^{2}\parallel E\parallel^{2}_{\infty}+\textbf{b}^{2}\\&&+2(\delta^{2}+\mu_{0}^{2}+\omega^{2}+\phi^{2})\bigg)\parallel V_{1}-V_{2}\parallel^{2}_{\infty},\\ \parallel Z_{3}(t,\,\,S,\,\,E,\,\,V_{1},\,\,I,\,\,R)-Z_{3}(t,\,\,S,\,\,E,\,\,V_{2},\,\,I,\,\,R)\parallel_{\infty}^{2}&\leq&\bar{K_{3}}\parallel V_{1}-V_{2}\parallel^{2}_{\infty}, \end{eqnarray}$

where

$\begin{eqnarray} \bar{K_{3}} = 4\parallel w^{'}\parallel^{2}_{\infty}\bigg(\rho_{2}^{2}\alpha^{2}\parallel E\parallel^{2}_{\infty}+\textbf{b}^{2}+2(\delta^{2}+\mu_{0}^{2}+\omega^{2}+\phi^{2})\bigg). \end{eqnarray}$

$\begin{eqnarray} \mid Z_{4}(t,\,\,S,\,\,E,\,\,V,\,\,I_{1},\,\,R)-Z_{4}(t,\,\,S,\,\,E,\,\,V,\,\,I_{2},\,\,R)\mid^{2}& = &\mid w^{'}(-\mu_{0}-\delta-\psi)\big](Q_{1}-Q_{2})\mid^{2},\\ \mid Z_{4}(t,\,\,S,\,\,E,\,\,V,\,\,I_{1},\,\,R)-Z_{4}(t,\,\,S,\,\,E,\,\,V,\,\,I_{2},\,\,R)\mid^{2}& = &\mid w^{'}\mid^{2}(3\mu_{0}^{2}+3\delta^{2}+3\psi^{2})\mid I_{1}-I_{2}\mid^{2},\\ \sup\limits_{t\in D_{I}}Z_{4}(t,\,\,S,\,\,E,\,\,V,\,\,I_{1},\,\,R)-Z_{4}(t,\,\,S,\,\,E,\,\,V,\,\,I_{2},\,\,R)\mid^{2}& = &\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}(3\mu_{0}^{2}+3\delta^{2}+3\psi^{2})\sup\limits_{t\in D_{I}}\mid I_{1}-I_{2}\mid^{2},\\ \parallel Z_{4}(t,\,\,S,\,\,E,\,\,V,\,\,I_{1},\,\,R)-Z_{4}(t,\,\,S,\,\,E,\,\,V,\,\,I_{2},\,\,R)\parallel_{\infty}^{2}&\leq&\parallel w^{'}\parallel^{2}_{\infty}(3\mu_{0}^{2}+3\delta^{2}+3\psi^{2})\parallel I_{1}-I_{2}\parallel^{2}_{\infty},\\ \parallel Z_{4}(t,\,\,S,\,\,E,\,\,V,\,\,I_{1},\,\,R)-Z_{4}(t,\,\,S,\,\,E,\,\,V,\,\,I_{2},\,\,R)\parallel_{\infty}^{2}&\leq&\bar{K_{4}}\parallel I_{1}-I_{2}\parallel^{2}_{\infty}, \end{eqnarray}$

where

$\begin{eqnarray} \bar{K_{4}} = \parallel w^{'}\parallel^{2}_{\infty}(3\mu_{0}^{2}+3\delta^{2}+3\psi^{2}). \end{eqnarray}$

$\begin{eqnarray} \mid Z_{5}(t,\,\,S,\,\,E,\,\,V,\,\,I,\,\,R_{1})-Z_{5}(t,\,\,S,\,\,E,\,\,V,\,\,I,\,\,R_{2})\mid^{2}& = &\mid w^{'}(-\delta)(R_{1}-R_{2})\mid^{2},\\ \mid Z_{5}(t,\,\,S,\,\,E,\,\,V,\,\,I,\,\,R_{1})-Z_{5}(t,\,\,S,\,\,E,\,\,V,\,\,I,\,\,R_{2})\mid^{2}&\leq&\mid w^{'}\mid^{2}\delta^{2}\mid(R_{1}-R_{2})\mid^{2},\\ \sup\limits_{t\in D_{R}}\mid Z_{5}(t,\,\,S,\,\,E,\,\,V,\,\,I,\,\,R_{1})-Z_{5}(t,\,\,S,\,\,E,\,\,V,\,\,I,\,\,R_{2})\mid^{2}&\leq&\sup\limits_{t\in D_{w^{'}}}\mid w^{'}\mid^{2}\delta^{2}\sup\limits_{t\in D_{R}}\mid R_{1}-R_{2}\mid^{2},\\ \parallel Z_{5}(t,\,\,S,\,\,E,\,\,V,\,\,I,\,\,R_{1})-Z_{5}(t,\,\,S,\,\,E,\,\,V,\,\,I,\,\,R_{2})\parallel_{\infty}^{2}&\leq&\parallel w^{'}\parallel^{2}_{\infty}\delta^{2}\parallel R_{1}-R_{2}\parallel_{\infty}^{2},\\ \parallel Z_{5}(t,\,\,S,\,\,E,\,\,V,\,\,I,\,\,R_{1})-Z_{5}(t,\,\,S,\,\,E,\,\,V,\,\,I,\,\,R_{2})\parallel_{\infty}^{2}&\leq&\bar{K_{5}}\parallel R_{1}-R_{2}\parallel^{2}_{\infty}, \end{eqnarray}$

involving

$\begin{eqnarray} \bar{K_{5}} = \parallel w^{'}\parallel^{2}_{\infty}\delta^{2}. \end{eqnarray}$

Then, given the condition, system (2.2) has a particular solution.

$\begin{eqnarray} \max\Big[\frac{3}{\textbf{a}^{2}}(\rho^{2}+\delta^{2}+\rho_{1}^{2}),\frac{(\delta^{2}+\rho^{2}_{2}\alpha^{2}\parallel V \parallel^{2}_{\infty})}{(\rho^{2}+\rho_{1}^{2})\parallel S\parallel^{2}_{\infty}},\frac{2(\delta^{2}+\mu_{0}^{2}+\omega^{2}+\phi^{2})}{\left(\rho_{2}^{2}\alpha^{2}\parallel E\parallel^{2}_{\infty}+\textbf{b}^{2}\right)},\frac{3(\mu_{0}^{2}+\delta^{2}+\psi^{2})}{\phi^{2}\parallel V \parallel^{2}_{\infty}},\\ \frac{\delta^{2}}{2(\omega^{2}\parallel V \parallel^{2}_{\infty}+\psi^{2}\parallel I \parallel^{2}_{\infty})}\Big] < 1. \end{eqnarray}$

5. Global stability for developed system

We use Lyapunov's approach and LaSalle's concept of invariance to analyze global stability and determine the conditions for eliminating diseases.

5.1. Lyapunov's first derivative

Theorem 5.1. ^[41] When the reproductive number $R_{0} >$ 1, the endemic equilibrium points of the SEVIR model are globally asymptotically stable.

Proof. The Lyapunov function can be expressed in the following manner:

$\begin{eqnarray} L(S^{*},E^{*},V^{*},I^{*},R^{*})& = &\left(S-S^{*}-S^{*}\log\frac{S}{S^{*}}\right)+\left(E-E^{*}-E^{*}\log\frac{E}{E^{*}}\right) +\left(V-V^{*}-V^{*}\log\frac{V}{V^{*}}\right)\\ &&+\left(I-I^{*}-I^{*}\log\frac{I}{I^{*}}\right)+\left(R-R^{*}-R^{*}\log\frac{R}{R^{*}}\right). \end{eqnarray}$

By applying a derivative on both sides,

$\begin{eqnarray} D^{\xi,\lambda}_{t} L = \dot{L} = \left(\frac{S-S^{*}}{S}\right)D^{\xi,\lambda}_{t}S+\left(\frac{E-E^{*}}{E}\right)D^{\xi,\lambda}_{t}E+\left(\frac{V-V^{*}}{V}\right)D^{\xi,\lambda}_{t}V+\left(\frac{I-I^{*}}{I}\right)D^{\xi,\lambda}_{t}I+\left(\frac{R-R^{*}}{R}\right)D^{\xi,\lambda}_{t}R, \end{eqnarray}$

we get

$\begin{eqnarray} D^{\xi,\lambda}_{t} L & = &\left(\frac{S-S^{*}}{S}\right)\left(\textbf{a}-(\delta+\rho+\rho_{1})S\right) +\left(\frac{E-E^{*}}{E}\right)\left((\rho+\rho_{1})S-\delta E-\rho_{2}\alpha E V\right)+\left(\frac{V-V^{*}}{V}\right)\\&&\times\left(\rho_{2}\alpha E V -(\delta+\mu_{0}+\omega-\textbf{b}+\phi)V\right)+\left(\frac{I-I^{*}}{I}\right)\left(\phi V-(\mu_{0}+\delta+\psi)I\right)+\left(\frac{R-R^{*}}{R}\right)\\&&\times\left(\omega V+\psi I-\delta R\right), \end{eqnarray}$

and setting $S = S-S^{*}, E = E-E^{*}, V = V-V^{*}, I = I-I^{*}$ and $R = R-R^{*}$ results in

$\begin{eqnarray} D^{\xi,\lambda}_{t} L& = &\textbf{a}-\textbf{a}\frac{S^{*}}{S}-(\delta+\rho+\rho_{1})\frac{(S-S^{*})^{2}}{S} +(\rho+\rho_{1})S-(\rho+\rho_{1})S^{*}-(\rho+\rho_{1})S\frac{E^{*}}{E}+(\rho+\rho_{1})S^{*}\frac{E^{*}}{E} \\&&-\delta\frac{(E-E^{*})^{2}}{E}-\rho_{2}\alpha V\frac{(E-E^{*})^{2}}{E}+\rho_{2}\alpha V^{*}\frac{(E-E^{*})^{2}}{E}+\rho_{2}\alpha E\frac{(V-V^{*})^{2}}{V}-\rho_{2}\alpha E^{*}\frac{(V-V^{*})^{2}}{V} \\&&+\textbf{b}\frac{(V-V^{*})^{2}}{V}-(\delta+\mu_{0}+\omega+\phi)\frac{(V-V^{*})^{2}}{V}+\phi V-\phi V^{*}-\phi V\frac{I^{*}}{I}+\phi V^{*}\frac{I^{*}}{I}\\&&-(\mu_{0}+\delta+\psi)\frac{(I-I^{*})^{2}}{I}+\omega V -\omega V^{*}-\omega V\frac{R^{*}}{R}+\omega V^{*}\frac{R^{*}}{R}+\psi I-\psi I^{*}\\&&-\psi I\frac{R^{*}}{R}+\psi I^{*}\frac{R^{*}}{R}-\delta\frac{(R-R^{*})^{2}}{R}. \end{eqnarray}$

We can write $D^{\xi, \lambda}_{t} L = \Sigma-\Omega$ , where

$\begin{eqnarray} \Sigma& = &\textbf{a}+(\rho+\rho_{1})S+(\rho+\rho_{1})S^{*}\frac{E^{*}}{E}+\rho_{2}\alpha V^{*}\frac{(E-E^{*})^{2}}{E}+\rho_{2}\alpha E\frac{(V-V^{*})^{2}}{V}+\textbf{b}\frac{(V-V^{*})^{2}}{V} +\phi V\\&&+\phi V^{*}\frac{I^{*}}{I}+\omega V+\omega V^{*}\frac{R^{*}}{R}+\psi I+\psi I^{*}\frac{R^{*}}{R}, \end{eqnarray}$

and

$\begin{eqnarray} \Omega& = &\textbf{a}\frac{S^{*}}{S}+(\delta+\rho+\rho_{1})\frac{(S-S^{*})^{2}}{S}+(\rho+\rho_{1})S^{*} +(\rho+\rho_{1})S\frac{E^{*}}{E}+\delta\frac{(E-E^{*})^{2}}{E}+\rho_{2}\alpha V\frac{(E-E^{*})^{2}}{E}\\&&+\rho_{2}\alpha E^{*}\frac{(V-V^{*})^{2}}{V}+(\delta+\mu_{0}+\omega+\phi)\frac{(V-V^{*})^{2}}{V}+\phi V^{*}+\phi V\frac{I^{*}}{I}+(\mu_{0}+\delta+\psi)\frac{(I-I^{*})^{2}}{I} +\omega V^{*}\\&&+\omega V\frac{R^{*}}{R}+\psi V^{*}+\psi I\frac{R^{*}}{R}+\delta\frac{(R-R^{*})^{2}}{R}. \end{eqnarray}$

We conclude that if $\Sigma < \Omega$ , this yields $D^{\xi, \lambda}_{t} L < 0$ , however when $S = S^{*}, E = E^{*}, V = V^{*}, I = I^{*}$ and $R = R^{*}$ , $\Sigma-\Omega = 0 \quad \Rightarrow D^{\xi, \lambda}_{t} L = 0$ .

We can observe that $\left\{(S^{*}, E^{*}, V^{*}, I^{*}, R^{*})\in\Gamma : D^{\xi, \lambda}_{t} L = 0\right\}$ represents the point $D_2$ for the developed model.

According to Lasalles' concept of invariance, $D_2$ is globally uniformly stable in $\Gamma$ if $\Sigma-\Omega = 0$ .

6. Solutions by fractal-fractional operator

Now, we will develop a solution using a numerical approach for our newly developed model given in Eq (2.2). We use the ML kernel in the current scenario instead of the classical derivative operator.

Furthermore, we will use the variable order version.

$\begin{eqnarray} ^{FFM}_{0}D^{\xi,\lambda}_{t} S(t)& = &\textbf{a}-(\delta+\rho+\rho_{1})S,\\ ^{FFM}_{0}D^{\xi,\lambda}_{t} E(t)& = &(\rho+\rho_{1})S-\delta E-\rho_{2}\alpha E V,\\ ^{FFM}_{0}D^{\xi,\lambda}_{t} V(t)& = &\rho_{2}\alpha E V-(\delta+\mu_{0}+\omega-\textbf{b}+\phi)V,\\ ^{FFM}_{0}D^{\xi,\lambda}_{t} I(t)& = &\phi V-(\mu_{0}+\delta+\psi)I,\\ ^{FFM}_{0}D^{\xi,\lambda}_{t} R(t)& = &\omega V+\psi I-\delta R. \end{eqnarray}$

For clarity, we express the above equation as follows:

$\begin{eqnarray} ^{FFM}_{0}D^{\xi,\lambda}_{t} S(t)& = &S_{1}(t, S, G),\\ ^{FFM}_{0}D^{\xi,\lambda}_{t} E(t)& = &E_{1}(t, S, G),\\ ^{FFM}_{0}D^{\xi,\lambda}_{t} V(t)& = &V_{1}(t, S, G),\\ ^{FFM}_{0}D^{\xi,\lambda}_{t} I(t)& = &I_{1}(t, S, G),\\ ^{FFM}_{0}D^{\xi,\lambda}_{t} R(t)& = &R_{1}(t, S, G). \end{eqnarray}$

Where

$\begin{eqnarray} S_{1}(t, S, G)& = &\textbf{a}-(\delta+\rho+\rho_{1})S,\\ E_{1}(t, S, G)& = &(\rho+\rho_{1})S-\delta E-\rho_{2}\alpha E V,\\ V_{1}(t, S, G)& = &\rho_{2}\alpha E V-(\delta+\mu_{0}+\omega-\textbf{b}+\phi)V,\\ I_{1}(t, S, G)& = &\phi V-(\mu_{0}+\delta+\psi)I,\\ R_{1}(t, S, G)& = &\omega V+\psi I-\delta R. \end{eqnarray}$

After using the fractal-fractional integral with the ML kernel, we obtain the following results:

$\begin{eqnarray} S(t_{\eta}+1)& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}S_{1}\left(t_{\eta},S(t_{\eta}),G(t_{\eta})\right)\\&&+ \frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\int_{t_{\nu}}^{t_{\nu+1}}S_{1}(t,S,G)\tau^{\xi-1}(t_{\eta+1} -\tau)^{\xi-1}{d}\tau,\\ E(t_{\eta}+1)& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}E_{1}\left(t_{\eta},S(t_{\eta}),G(t_{\eta})\right) \\&&+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\int_{t_{\nu}}^{t_{\nu+1}}E_{1}(t,S,G)\tau^{\xi-1}(t_{\eta+1} -\tau)^{\xi-1}{d}\tau,\\ V(t_{\eta}+1)& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}V_{1}\left(t_{\eta},S(t_{\eta}),G(t_{\eta})\right) \\&&+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\int_{t_{\nu}}^{t_{\nu+1}}V_{1}(t,S,G)\tau^{\xi-1}(t_{\eta+1} -\tau)^{\xi-1}{d}\tau,\\ I(t_{\eta}+1)& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}I_{1}\left(t_{\eta},S(t_{\eta}),G(t_{\eta})\right) \\&&+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\int_{t_{\nu}}^{t_{\nu+1}}I_{1}(t,S,G)\tau^{\xi-1}(t_{\eta+1} -\tau)^{\xi-1}{d}\tau,\\ R(t_{\eta}+1)& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}R_{1}\left(t_{\eta},S(t_{\eta}),G(t_{\eta})\right) \\&&+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\int_{t_{\nu}}^{t_{\nu+1}}R_{1}(t,S,G)\tau^{\xi-1}(t_{\eta+1} -\tau)^{\xi-1}{d}\tau, \end{eqnarray}$

(6.1)

where $G(t_{\eta}) = E(t_{\eta}), \, \, V(t_{\eta}), \, \, I(t_{\eta}), \, \, R(t_{\eta})$ .

Remember that the Newton polynomial can be obtained by using the Newton interpolation formula.

$\begin{eqnarray} N(t, S, G)&\simeq&N(t_{\eta-2},S_{\eta-2},G_{\eta-2})+\frac{1}{\Delta t}\Big[N(t_{\eta-1},S_{\eta-1},G_{\eta-1})\\ &-&N(t_{\eta-2},S_{\eta-2},G_{\eta-2})\Big]\left(\tau-t_{\eta-2}\right)+\frac{1}{2\Delta t^{2}}\Big[N(t_{\eta},S_{\eta},E_{\eta},I_{\eta},Q_{\eta},R_{\eta})\\ &-&2N(t_{\eta-1},S_{\eta-1},G_{\eta-1})-N(t_{\eta-2},S_{\eta-2},G_{\eta-2})\Big] \left(\tau-t_{\eta-2}\right)\left(\tau-t_{\eta-1}\right), \end{eqnarray}$

where $G_{\eta-2} = E_{\eta-2}, V_{\eta-2}, I_{\eta-2}, R_{\eta-2}$ , $G_{\eta-1} = E_{\eta-1}, V_{\eta-1}, I_{\eta-1}, R_{\eta-1}$ .

When we substitute the Newton polynomial into the system of Eqs (6.1), we obtain the following:

$\begin{eqnarray} S^{\eta+1}& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}S_{1}(t_{\eta},S(t_{\eta}),G(t_{\eta}))+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}S_{1} (t_{\nu-2},S^{\nu-2},G^{\nu-2})\\&&\times t^{\lambda-1}_{\nu-2} \int_{t_{\nu}}^{t_{\nu+1}}(t_{\eta+1}-\tau)^{\xi-1}{d}\tau +\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\frac{1}{\Delta t}\Big[t^{\lambda-1}_{\nu-1}S_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1}) \\&&-t^{\lambda-1}_{\nu-2} S_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \int_{t_{\nu}}^{t_{\nu+1}}(\tau-t_{\nu-2})(t_{\eta+1}-\tau)^{\xi-1}{d}\tau\\&&+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\frac{1}{2\Delta t^{2}}\Big[t^{\lambda-1}_{\nu}S_{1}(t_{\nu},S^{\nu},G^{\nu}) -2t^{\lambda-1}_{\nu-1}S_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\&&+t^{\lambda-1}_{\nu-2} S_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \int_{t_{\nu}}^{t_{\nu+1}}(\tau-t_{\nu-2})(\tau-t_{\nu-1})(t_{\eta+1}-\tau)^{\xi-1}{d}\tau.\\ E^{\eta+1}& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}E_{1}(t_{\eta},S(t_{\eta}),G(t_{\eta}))+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}E_{1} (t_{\nu-2},S^{\nu-2},G^{\nu-2})\\&&\times t^{\lambda-1}_{\nu-2}\int_{t_{\nu}}^{t_{\nu+1}}(t_{\eta+1}-\tau)^{\xi-1}{d}\tau\ +\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\frac{1}{\Delta t}\Big[t^{\lambda-1}_{\nu-1}E_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\ &&-t^{\lambda-1}_{\nu-2} E_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \int_{t_{\nu}}^{t_{\nu+1}}(\tau-t_{\nu-2})(t_{\eta+1}-\tau)^{\xi-1}{d}\tau\\ &&+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\frac{1}{2\Delta t^{2}}\Big[t^{\lambda-1}_{\nu} E_{1}(t_{\nu},S^{\nu},G^{\nu}) -2t^{\lambda-1}_{\nu-1}E_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\&&+t^{\lambda-1}_{\nu-2} E_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \int_{t_{\nu}}^{t_{\nu+1}}(\tau-t_{\nu-2})(\tau-t_{\nu-1})(t_{\eta+1}-\tau)^{\xi-1}{d}\tau.\\ V^{\eta+1}& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}V_{1}(t_{\eta},S(t_{\eta}),G(t_{\eta}))+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}V_{1} (t_{\nu-2},S^{\nu-2},G^{\nu-2})\\&&\times t^{\lambda-1}_{\nu-2}\int_{t_{\nu}}^{t_{\nu+1}}(t_{\eta+1}-\tau)^{\xi-1}{d}\tau +\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\frac{1}{\Delta t} \Big[t^{\lambda-1}_{\nu-1} V_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\ &&-t^{\lambda-1}_{\nu-2} V_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \int_{t_{\nu}}^{t_{\nu+1}}(\tau-t_{\nu-2})(t_{\eta+1}-\tau)^{\xi-1}{d}\tau\\&&+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\frac{1}{2\Delta t^{2}}\Big[t^{\lambda-1}_{\nu}V_{1}(t_{\nu},S^{\nu},G^{\nu}) -2t^{\lambda-1}_{\nu-1}V_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\&&+t^{\lambda-1}_{\nu-2} V_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \int_{t_{\nu}}^{t_{\nu+1}}(\tau-t_{\nu-2})(\tau-t_{\nu-1})(t_{\eta+1}-\tau)^{\xi-1}{d}\tau.\\ I^{\eta+1}& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}I_{1}(t_{\eta},S(t_{\eta}),G(t_{\eta}))+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}I_{1} (t_{\nu-2},S^{\nu-2},G^{\nu-2})\\ &&\times t^{\lambda-1}_{\nu-2}\int_{t_{\nu}}^{t_{\nu+1}}(t_{\eta+1}-\tau)^{\xi-1}{d}\tau +\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\frac{1}{\Delta t}\Big[t^{\lambda-1}_{\nu-1} I_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\&&-t^{\lambda-1}_{\nu-2} I_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \int_{t_{\nu}}^{t_{\nu+1}}(\tau-t_{\nu-2})(t_{\eta+1}-\tau)^{\xi-1}{d}\tau\\ &&+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\frac{1}{2\Delta t^{2}}\Big[t^{\lambda-1}_{\nu}I_{1}(t_{\nu},S^{\nu},G^{\nu}) -2t^{\lambda-1}_{\nu-1}Q_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\&&+t^{\lambda-1}_{\nu-2} I_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \int_{t_{\nu}}^{t_{\nu+1}}(\tau-t_{\nu-2})(\tau-t_{\nu-1})(t_{\eta+1}-\tau)^{\xi-1}{d}\tau.\\ R^{\eta+1}& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}R_{1}(t_{\eta},S(t_{\eta}),G(t_{\eta}))+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}R_{1} (t_{\nu-2},S^{\nu-2},G^{\nu-2})\\&&\times t^{\lambda-1}_{\nu-2}\int_{t_{\nu}}^{t_{\nu+1}}(t_{\eta+1} -\tau)^{\xi-1}{d}\tau\ +\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\frac{1}{\Delta t}\Big[t^{\lambda-1}_{\nu-1}R_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\ &&-t^{\lambda-1}_{\nu-2}R_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \int_{t_{\nu}}^{t_{\nu+1}}(\tau-t_{\nu-2})(t_{\eta+1}-\tau)^{\xi-1}{d}\tau\\ &&+\frac{\xi \lambda}{A B(\xi)\Gamma(\xi)}\sum^{\eta}_{\nu = 2}\frac{1}{2\Delta t^{2}}\Big[t^{\lambda-1}_{\nu}R_{1}(t_{\nu},S^{\nu},G^{\nu}) -2t^{\lambda-1}_{\nu-1}R_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\&&+t^{\lambda-1}_{\nu-2} R_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \int_{t_{\nu}}^{t_{\nu+1}}(\tau-t_{\nu-2})(\tau-t_{\nu-1})(t_{\eta+1}-\tau)^{\xi-1}{d}\tau, \end{eqnarray}$

(6.2)

where $G^{\nu-2} = E^{\nu-2}, V^{\nu-2}, I^{\nu-2}, R^{\nu-2}$ , $G^{\nu-1} = E^{\nu-1}, V^{\nu-1}, I^{\nu-1}, R^{\nu-1}$ , $G^{\nu} = E^{\nu}, V^{\nu}, I^{\nu}, R^{\nu}$ , and $G(t_{\eta}) = E(t_{\eta}), V(t_{\eta}), I(t_{\eta}), R(t_{\eta})$ .

We can perform the following calculations for the integral in Eq (6.2):

$\begin{eqnarray} \int_{t_{\nu}}^{t_{\nu+1}}(t_{\eta+1}-\tau)^{\xi-1}{d}\tau& = &\frac{(\Delta t)^{\xi}}{\xi}\Big[(\eta-\nu+1)^{\xi}-(\eta-\nu)^{\xi}\Big],\\ \int_{t_{\nu}}^{t_{\nu+1}}(\tau-t_{\nu-2})(t_{\eta+1}-\tau)^{\xi-1}{d}\tau& = &\frac{(\Delta t)^{\xi+1}}{\xi(\xi+1)}\Big[(\eta-\nu+1)^{\xi}\\&&\times (\eta-\nu+3+2\xi)-(\eta-\nu)^{\xi}(\eta-\nu+3+3\xi)\Big].\\ \int_{t_{\nu}}^{t_{\nu+1}}(\tau-t_{\nu-2})(\tau-t_{\nu-1})(t_{\eta+1}-\tau)^{\xi-1}{d}\tau& = &\frac{(\Delta t)^{\xi+2}}{\xi(\xi+1)(\xi+2)}\Big[(\eta-\nu+1)^{\xi}\Big\{2(\eta-\nu)^{2}+(3\xi+10)\\&&\times(\eta-\nu)+2\xi^{2}+9\xi+12\Big\}-(\eta-\nu)^{\xi}\Big\{2(\eta-\nu)^{2}\\ &&+(5\xi+10)(\eta-\nu)+6\xi^{2}+18\xi+12\Big\}\Big], \end{eqnarray}$

(6.3)

substituting integral calculation values into Eq (6.2).

We acquire the numerical solutions $S(t), E(t), V(t), I(t)\, \, and \, \, R(t)$ :

$\begin{eqnarray} S^{\eta+1}& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}S_{1}(t_{\eta},S(t_{\eta}),G(t_{\eta})) +\frac{\xi \lambda(\Delta t)^{\xi}}{A B(\xi)\Gamma(\xi+1)}\sum^{\eta}_{\nu = 2} S_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\\&&\times t^{\lambda-1}_{\nu-2} \Big[(\eta-\nu+1)^{\xi}-(\eta-\nu)^{\xi}\Big]+\frac{\xi \lambda(\Delta t)^{\xi}}{A B(\xi)\Gamma(\xi+2)}\sum^{\eta}_{\nu = 2} \Big[t^{\lambda-1}_{\nu-1}S_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\&&- t^{\lambda-1}_{\nu-2}S_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \Big[(\eta-\nu+1)^{\xi}(\eta-\nu+3+2\xi)-(\eta-\nu)^{\xi}(\eta-\nu+3+3\xi)\Big]\\&&+\frac{\xi \lambda(\Delta t)^{\xi}}{2A B(\xi)\Gamma(\xi+3)}\sum^{\eta}_{\nu = 2}\Big[t^{\lambda-1}_{\nu}S_{1} (t_{\nu},S^{\nu},G^{\nu}) -2t^{\lambda-1}_{\nu-1}S_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\ &&+t^{\lambda-1}_{\nu-2}S_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \Big[(\eta-\nu+1)^{\xi}\Big\{2(\eta-\nu)^{2}+(3\xi+10)(\eta-\nu)+2\xi^{2}+9\xi+12\Big\}\\ &&-(\eta-\nu)^{\xi}\times\Big\{2(\eta-\nu)^{2}+(5\xi+10)(\eta-\nu)+6\xi^{2}+18\xi+12\Big\}\Big],\\ E^{\eta+1}& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}E_{1}(t_{\eta},S(t_{\eta}),G(t_{\eta})) +\frac{\xi \lambda(\Delta t)^{\xi}}{A B(\xi)\Gamma(\xi+1)}\sum^{\eta}_{\nu = 2} E_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\\&&\times t^{\lambda-1}_{\nu-2} \Big[(\eta-\nu+1)^{\xi}-(\eta-\nu)^{\xi}\Big]+\frac{\xi \lambda(\Delta t)^{\xi}}{A B(\xi)\Gamma(\xi+2)}\sum^{\eta}_{\nu = 2} \Big[t^{\lambda-1}_{\nu-1}E_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\ &&- t^{\lambda-1}_{\nu-2}E_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \Big[(\eta-\nu+1)^{\xi}(\eta-\nu+3+2\xi)-(\eta-\nu)^{\xi}(\eta-\nu+3+3\xi)\Big]\\ &&+\frac{\xi \lambda(\Delta t)^{\xi}}{2A B(\xi)\Gamma(\xi+3)}\sum^{\eta}_{\nu = 2}\Big[t^{\lambda-1}_{\nu}E_{1} (t_{\nu},S^{\nu},G^{\nu}) -2t^{\lambda-1}_{\nu-1}E_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\ &&+t^{\lambda-1}_{\nu-2}E_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \Big[(\eta-\nu+1)^{\xi}\Big\{2(\eta-\nu)^{2}+(3\xi+10)(\eta-\nu)+2\xi^{2}+9\xi+12\Big\}\\&&- (\eta-\nu)^{\xi}\times\Big\{2(\eta-\nu)^{2}+(5\xi+10)(\eta-\nu)+6\xi^{2}+18\xi+12\Big\}\Big],\\ V^{\eta+1}& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}V_{1}(t_{\eta},S(t_{\eta}),G(t_{\eta}))+\frac{\xi \lambda(\Delta t)^{\xi}}{A B(\xi)\Gamma(\xi+1)}\sum^{\eta}_{\nu = 2} V_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\\&&\times t^{\lambda-1}_{\nu-2} \Big[(\eta-\nu+1)^{\xi}-(\eta-\nu)^{\xi}\Big]+\frac{\xi \lambda(\Delta t)^{\xi}}{A B(\xi)\Gamma(\xi+2)}\sum^{\eta}_{\nu = 2} \Big[t^{\lambda-1}_{\nu-1}V_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\&&- t^{\lambda-1}_{\nu-2}V_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \Big[(\eta-\nu+1)^{\xi}(\eta-\nu+3+2\xi)-(\eta-\nu)^{\xi}(\eta-\nu+3+3\xi)\Big]\\ &&+\frac{\xi \lambda(\Delta t)^{\xi}}{2A B(\xi)\Gamma(\xi+3)}\sum^{\eta}_{\nu = 2}\Big[t^{\lambda-1}_{\nu}V_{1} (t_{\nu},S^{\nu},G^{\nu}) -2t^{\lambda-1}_{\nu-1}V_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\ &&+t^{\lambda-1}_{\nu-2}V_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \Big[(\eta-\nu+1)^{\xi}\Big\{2(\eta-\nu)^{2}+(3\xi+10)(\eta-\nu)+2\xi^{2}+9\xi+12\Big\}\\&&- (\eta-\nu)^{\xi}\times\Big\{2(\eta-\nu)^{2}+(5\xi+10)(\eta-\nu)+6\xi^{2}+18\xi+12\Big\}\Big],\\ I^{\eta+1}& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}I_{1}(t_{\eta},S(t_{\eta}),G(t_{\eta})) +\frac{\xi \lambda(\Delta t)^{\xi}}{A B(\xi)\Gamma(\xi+1)}\sum^{\eta}_{\nu = 2} I_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\\&&\times t^{\lambda-1}_{\nu-2} \Big[(\eta-\nu+1)^{\xi}-(\eta-\nu)^{\xi}\Big]+\frac{\xi \lambda(\Delta t)^{\xi}}{A B(\xi)\Gamma(\xi+2)}\sum^{\eta}_{\nu = 2} \Big[t^{\lambda-1}_{\nu-1}I_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\ &&-t^{\lambda-1}_{\nu-2}I_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \Big[(\eta-\nu+1)^{\xi}(\eta-\nu+3+2\xi)-(\eta-\nu)^{\xi}(\eta-\nu+3+3\xi)\Big]\\&&+\frac{\xi \lambda(\Delta t)^{\xi}}{2A B(\xi)\Gamma(\xi+3)}\sum^{\eta}_{\nu = 2}\Big[t^{\lambda-1}_{\nu}I_{1} (t_{\nu},S^{\nu},G^{\nu}) -2t^{\lambda-1}_{\nu-1}I_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\ &&+t^{\lambda-1}_{\nu-2}I_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \Big[(\eta-\nu+1)^{\xi}\Big\{2(\eta-\nu)^{2}+(3\xi+10)(\eta-\nu)+2\xi^{2}+9\xi+12\Big\}\\ &&-(\eta-\nu)^{\xi}\times\Big\{2(\eta-\nu)^{2}+(5\xi+10)(\eta-\nu)+6\xi^{2}+18\xi+12\Big\}\Big],\\ R^{\eta+1}& = &\frac{\lambda(1-\xi)}{A B(\xi)}t_{\eta}^{\lambda-1}R_{1}(t_{\eta},S(t_{\eta}),G(t_{\eta}))+\frac{\xi \lambda(\Delta t)^{\xi}}{A B(\xi)\Gamma(\xi+1)}\sum^{\eta}_{\nu = 2} R_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\\&&\times t^{\lambda-1}_{\nu-2} \Big[(\eta-\nu+1)^{\xi}-(\eta-\nu)^{\xi}\Big]+\frac{\xi \lambda(\Delta t)^{\xi}}{A B(\xi)\Gamma(\xi+2)}\sum^{\eta}_{\nu = 2} \Big[t^{\lambda-1}_{\nu-1}R_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\&&- t^{\lambda-1}_{\nu-2}R_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \Big[(\eta-\nu+1)^{\xi}(\eta-\nu+3+2\xi)-(\eta-\nu)^{\xi}(\eta-\nu+3+3\xi)\Big]\\ &&+\frac{\xi \lambda(\Delta t)^{\xi}}{2 A B(\xi)\Gamma(\xi+3)}\sum^{\eta}_{\nu = 2}\Big[t^{\lambda-1}_{\nu}R_{1} (t_{\nu},S^{\nu},G^{\nu}) -2t^{\lambda-1}_{\nu-1}R_{1}(t_{\nu-1},S^{\nu-1},G^{\nu-1})\\ &&+t^{\lambda-1}_{\nu-2}R_{1}(t_{\nu-2},S^{\nu-2},G^{\nu-2})\Big] \Big[(\eta-\nu+1)^{\xi}\Big\{2(\eta-\nu)^{2}+(3\xi+10)(\eta-\nu)+2\xi^{2}+9\xi+12\Big\}\\&&-(\eta-\nu)^{\xi}\times\Big\{2(\eta-\nu)^{2}+(5\xi+10)(\eta-\nu)+6\xi^{2}+18\xi+12\Big\}\Big]. \end{eqnarray}$

7. Simulation explanation

In this section, we utilized an advanced technique to obtain theoretical outcomes and assess their effectiveness. The newly developed SEVIR system was analyzed through simulation. By applying non-integer parametric values in the SARS-COVID-19 model, we obtained interesting findings. – display the solutions for $S(t)$ , $E(t)$ , $V(t)$ , $I(t)$ , and $R(t)$ by reducing the fractional values to the desired level. To validate the efficiency of the theoretical outcomes, we provide the following examples. Numerical simulations for the SARS-COVID-19 model were performed using MATLAB. The initial conditions used in the newly developed model are $S(0) = 217.342565, E(0) = 100, V(0) = 1.386348, I(0) = 1.1$ and $R(0) = 1.271087$ . The parameter values used in the developed system are as follows: $\textbf{a} = 1.43$ , $\delta = 0.000065$ , $\rho = 0.45$ , $\rho_{1} = 0.10$ , $\rho_{2} = 0.020$ , $\alpha = 0.0008601$ , $\mu_{0} = 0.19$ , $\omega = 0.98$ , $\textbf{b} = 0.135$ , $\phi = 0.0001$ , and $\psi = 0.0001$ . Figures 2, 4, and 5 illustrate the changes in susceptible, vaccinated, and infected individuals respectively, showing a sharp decrease before reaching a stable position. Meanwhile, Figures 3 and 6 demonstrate the dynamics of exposed and recovered individuals respectively at different fractional orders in which both individuals increases and after certain time the number of individuals approaches stable state using different dimensions. The research predicts future infection rates and suggests ways to decrease the spread of infection units more effectively. By utilizing a fractal-fractional approach, the study yields reliable and accurate results for all compartments at non-integer order derivatives, which are more trustworthy when fractional values are reduced as well a by reducing its dimensions. The findings suggest that the number of infected individuals decreases significantly due to vaccination measures, while the number of recovered individuals increases due to a decline in infected individuals and the effect of vaccination.

Figure 2. The value of

$S(t)$ using the fractal-fractional operator with various fractional values at different dimensions.

DownLoad: Full-Size Img PowerPoint

Figure 3. The value of

$E(t)$ using the fractal-fractional operator with various fractional values at different dimensions.

DownLoad: Full-Size Img PowerPoint

Figure 4. The value of

$V(t)$ using the fractal-fractional operator with various fractional values at different dimensions.

DownLoad: Full-Size Img PowerPoint

Figure 5. The value of

$I(t)$ using the fractal-fractional operator with various fractional values at different dimensions.

DownLoad: Full-Size Img PowerPoint

Figure 6. The value of

$R(t)$ using the fractal-fractional operator with various fractional values at different dimensions.

DownLoad: Full-Size Img PowerPoint

8. Conclusions

This article employs a fractional order SEVIR model for SARS-COVID-19 with vaccinated effects using an FFO to find reliable solutions. We provide advice on controlling this virus to help our community overcome the pandemic by implementing vaccinated measures for low immune individuals. We analyze the dangerous coronavirus disease with the effect of vaccination to understand its real impact on the community. Qualitative and quantitative analyses are conducted to verify its stable position in a continuous dynamical system. We also verify that the fractional order coronavirus disease model has bounded and unique solutions. We examine the impact of global measures to control the spread of the coronavirus disease. Also, analyses are performed to see how the rate of infection changes after the implementation of vaccination measures. We ensure that our findings are reliable and realistic. FFO is used for continuously monitoring the spread as well as control of the disease in society after vaccination measures. It was observed that infected individuals recover quickly due to the vaccinated strategy. The fractal-fractional operator (FFO) is used for continuously monitoring for the spread of the diseases using different fractional values as well as reliable solutions. In fractal-fractional operators, fractal represents the dimensions of the spread of the disease, and fractional represents the fractional ordered derivative operator which provides the real behavior of the spread as well as control of COVID-19 with different dimensions and continuous monitoring, which can be observed in simulation. We conduct numerical simulations to observe how the disease controlled in the community after the implementation of vaccination measures using different fractional values with different dimensions. Additionally, future estimates are provided based on our findings, which can help in mitigating the risk of the disease spreading in the environment.

Use of AI tools declaration

The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

Acknowledgments

The authors would like to extend their sincere appreciation to Researchers Supporting Project number (RSP2024R472), King Saud University, Riyadh, Saudi Arabia.

Conflict of interest

All authors declare no conflicts of interest in this paper.

References

[1]	R. Eftimie, J. L. Bramson, D. J. D. Earn, Interactions between the immune system and cancer: a brief review of non-spatial mathematical models, Bull. Math. Biol., 73 (2011), 2–32. https://doi.org/10.1007/s11538-010-9526-3 doi: 10.1007/s11538-010-9526-3
[2]	K. Dehingia, H. K. Sarmah, M. B. Jeelani, A brief review on cancer research and its treatment through mathematical modelling, Ann. Cancer Res. Ther., 29 (2021), 34–40. https://doi.org/10.4993/acrt.29.34 doi: 10.4993/acrt.29.34
[3]	V. A. Kuznetsov, I. A. Makalkin, M. A. Taylor, A. S. Perelson, Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis, Bull. Math. Biol., 56 (1994), 295–321. https://doi.org/10.1016/S0092-8240(05)80260-5 doi: 10.1016/S0092-8240(05)80260-5
[4]	M. Kolev, Mathematical modelling of the competition between tumors and immune system considering the role of the antibodies, Math. Comput. Modell., 37 (2003), 1143–1152. https://doi.org/10.1016/S0895-7177(03)80018-3 doi: 10.1016/S0895-7177(03)80018-3
[5]	M. Robertson-Tessi, A. El-Kareh, A. Goriely, A mathematical model of tumor-immune interactions, J. Theor. Biol., 294 (2012), 56–73. https://doi.org/10.1016/j.jtbi.2011.10.027 doi: 10.1016/j.jtbi.2011.10.027
[6]	K. Dehingia, H. K. Sarmah, Y. Alharbi, K. Hosseini, Mathematical analysis of a cancer model with time-delay in tumor-immune interaction and stimulation processes, Adv. Differ. Equ.-NY, 2021 (2021), 2273. https://doi.org/10.1186/s13662-021-03621-4 doi: 10.1186/s13662-021-03621-4
[7]	K. Dehingia, P. Das, R. K. Upadhyay, A. K. Misra, F. A. Rihan, K. Hosseini, Modelling and analysis of delayed tumour-immune system with hunting T-cells, Math. Comput. Simulat., 203 (2023), 669–684.
[8]	A. Das, K. Dehingia, H. K. Sarmah, K. Hosseini, K. Sadri, S. Salahshour, Analysis of a delay-induced mathematical model of cancer, Adv. Contin. Discrete Models, 15 (2022), 1–20. https://doi.org/10.1186/s13662-022-03688-7 doi: 10.1186/s13662-022-03688-7
[9]	E. Allison, A. D. Colton, A. D. Gorman, R. Kurt, M. Shainheit, A mathematical model of the effector cell response to cancer, Math. Comput. Model. Dyn. Syst., 39 (2004), 1313–1327. https://doi.org/10.1016/j.mcm.2004.06.010 doi: 10.1016/j.mcm.2004.06.010
[10]	D. Li, W. Ma, S. Guo, Stability of a mathematical model of tumor-induced angiogenesis, Nonlinear Anal. Model. Control, 21 (2016), 325–344. https://doi.org/10.15388/NA.2016.3.3 doi: 10.15388/NA.2016.3.3
[11]	H. Dritschel, S. L. Waters, A. Roller, H. M. Byrne, A mathematical model of cytotoxic and helper T cell interactions in a tumour microenvironment, Lett. Biomath., 5 (2018), S36–S68. https://doi.org/10.1080/23737867.2018.1465863 doi: 10.1080/23737867.2018.1465863
[12]	S. Ghosh, S. Banerjee, Mathematical modeling of cancer–immune system, considering the role of antibodies, Theory Biosci., 137 (2018), 67–78. https://doi.org/10.1007/s12064-018-0261-x doi: 10.1007/s12064-018-0261-x
[13]	Y. Shu, J. Huang, Y. Dong, Y. Takeuchi, Mathematical modeling and bifurcation analysis of pro- and anti-tumor macrophages, Appl. Math. Model., 88 (2020), 758–773. https://doi.org/10.1016/j.apm.2020.06.042 doi: 10.1016/j.apm.2020.06.042
[14]	P. Liu, X. Liu, Dynamics of a tumor-immune model considering targeted chemotherapy, Chaos Solit. Fractals, 98 (2017), 7–13. https://doi.org/10.1016/j.chaos.2017.03 doi: 10.1016/j.chaos.2017.03
[15]	V. A. Kuznetsov, G. D. Knott, Modeling tumor regrowth and immunotherapy, Math. Comput. Model., 33 (2001), 1275–1287. https://doi.org/10.1016/s0895-7177(00)00314-9 doi: 10.1016/s0895-7177(00)00314-9
[16]	D. Kirschner, J. C. Panetta, Modeling immunotherapy of the tumor-immune interaction, J. Math. Biol., 37 (1998), 235–252. https://doi.org/10.1007/s002850050127 doi: 10.1007/s002850050127
[17]	L. G. de Pillis, A. Eladdadi, A. E. Radunskaya, Modeling cancer-immune responses to therapy, J. Pharmacokinet. Pharmacodyn., 41 (2014), 461–478. https://doi.org/10.1007/s10928-014-9386-9 doi: 10.1007/s10928-014-9386-9
[18]	L. G. de Pillis, A. E. Radunskaya, The dynamics of an optimally controlled tumor model: a case study, Math. Comput. Model., 37 (2003), 1221–1244. https://doi.org/10.1016/s0895-7177(03)00133-x doi: 10.1016/s0895-7177(03)00133-x
[19]	L. G. de Pillis, A. E. Radunskaya, A mathematical tumor model with immune resistance and drug therapy: an optimal control approach, J. Theor. Med., 3 (2000), 79–100. https://doi.org/10.1080/10273660108833067 doi: 10.1080/10273660108833067
[20]	L. G. de Pillis, W. Gu, K. R. Fister, T. A. Head, K. Maples, A. Murugan, et al., Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls, Math. Biosci., 209 (2007), 292–315. https://doi.org/10.1016/j.mbs.2006.05.003 doi: 10.1016/j.mbs.2006.05.003
[21]	L. G. de Pillis, W. Gu, A. E. Radunskaya, Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations, J. Theor. Biol., 238 (2006), 841–862. https://doi.org/10.1016/j.jtbi.2005.06.037 doi: 10.1016/j.jtbi.2005.06.037
[22]	L. G. de Pillis, K. R. Fister, W. Gu, C. Collins, M. Daub, D. Gross, et al., Mathematical model creation for cancer chemo-immunotherapy, Comput. Math. Methods Med., 10 (2009), 165–184. https://doi.org/10.1080/17486700802216301 doi: 10.1080/17486700802216301
[23]	L. G. de Pillis, H. Savage, A. E. Radunskaya, Mathematical model of colorectal cancer with monoclonal antibody treatments, Journal of Advances in Medicine and Medical Research, 4 (2014), 3101–3131. https://doi.org/10.9734/BJMMR/2014/8393 doi: 10.9734/BJMMR/2014/8393
[24]	L. G. de Pillis, A. E. Radunskaya, C. L. Wiseman, A validated mathematical model of cell-mediated immune response to tumor growth, Cancer Res., 65 (2005), 7950–7958. https://doi.org/10.1158/0008-5472.CAN-05-0564 doi: 10.1158/0008-5472.CAN-05-0564
[25]	S. Chareyron, M. Alamir, Mixed immunotherapy and chemotherapy of tumors:Feedback design and model updating schemes, J. Theor. Biol., 258 (2009), 444–454. https://doi.org/10.1016/j.jtbi.2008.07.002 doi: 10.1016/j.jtbi.2008.07.002
[26]	F. Ansarizadeh, M. Singh, D. Richards, Modelling of tumor cells regression in response to chemotherapeutic treatment, Appl. Math. Model., 48 (2017), 96–112. https://doi.org/10.1016/j.apm.2017.03.045 doi: 10.1016/j.apm.2017.03.045
[27]	A. Arabameri, D. Asemani, J. Hajati, Mathematical modeling of in-vivo tumor-immune interactions for the cancer immunotherapy using matured dendritic cells, J. Biol. Syst., 26 (2018), 1–22. https://doi.org/10.1142/S0218339018500080 doi: 10.1142/S0218339018500080
[28]	M. A. Alqudah, Cancer treatment by stem cells and chemotherapy as a mathematical model with numerical simulations, Alex. Eng. J., 59 (2020), 1953–1957. https://doi.org/10.1016/j.aej.2019.12.025 doi: 10.1016/j.aej.2019.12.025
[29]	B. Dhar, P. K. Gupta, A. Yildirim, Dynamical behaviour of a tumour-immune model focusing on the dosage of targeted chemotherapeutic drug, Int. J. Comput. Math., 99 (2022), 2568–2582. https://doi.org/10.1080/00207160.2022.2074789 doi: 10.1080/00207160.2022.2074789
[30]	Z. Abernathy, K. Abernathy, J. Stevens, A mathematical model for tumor growth and treatment using virotherapy, AIMS Math., 5 (2020), 4135–4150. https://doi.org/10.3934/math.2020265 doi: 10.3934/math.2020265

Reader Comments

Your name:*

Email:*
© 2023 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)